Ajanta Pharma signs pact with Biocon for Semaglutide
Ajanta Pharma partners with Biocon to market Semaglutide in 26 countries, aiming for commercialization after 2026 regulatory approvals.
23 Dec 17:15 · The Hindu
last updated on 23 Dec 20:32